Add to ORKGDyslipidemia is a common problem affecting HIV-infected patients receiving antiretroviral therapy. Since publication of preliminary guidelines in 2000 [1], nu-merous studies have addressed the risk of cardiovas-cular disease, the mechanisms of dyslipidemia, drug interactions, and the treatment of lipid disorders in HIV-infected patients. In addition, updated recom-mendations from the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evalua-tion, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III [ATP III]) have been published [2] that materially affect the clinical approach to lipid disorders in the general population. A working group of clinical scientists, consisting of members of the Cardi...
Dyslipidemia is a change in serum lipids levels, which is associated with increased risk of cardiova...
AbstractMetabolic complications continue to play a major role in the management of HIV infection. Dy...
none6noThe introduction of potent combination antiretroviral therapy (cART) has had a remarkable imp...
Dyslipidemia is a common problem affecting HIV-infected patients receiving antiretroviral therapy. S...
Dyslipidemia is a prevalent condition that affects patients infected with human immunodeficiency vir...
Accumulating evidence suggests that HIV-infected individuals have an increased risk of cardiovascula...
Metabolic complications continue to play a major role in the management of HIV infection. Dyslipidem...
Metabolic complications continue to play a major role in the management of HIV infection. Dyslipidem...
The objective proposed by various health authorities for the year 2010 is to reduce CHD deaths to no...
The objective proposed by various health authorities for the year 2010 is to reduce CHD deaths to no...
AbstractMetabolic complications continue to play a major role in the management of HIV infection. Dy...
Dyslipidaemia is a common metabolic condition occurring in people with HIV (PWH), whether treated or...
Highly active antiretroviral therapy (HAART) reduces AIDS-related morbidity and mortality, however i...
The number of people that live with HIV continue to increase due to ample access to antiretroviral t...
Lipid abnormalities are prevalent among persons living with HIV infection and contribute to increasi...
Dyslipidemia is a change in serum lipids levels, which is associated with increased risk of cardiova...
AbstractMetabolic complications continue to play a major role in the management of HIV infection. Dy...
none6noThe introduction of potent combination antiretroviral therapy (cART) has had a remarkable imp...
Dyslipidemia is a common problem affecting HIV-infected patients receiving antiretroviral therapy. S...
Dyslipidemia is a prevalent condition that affects patients infected with human immunodeficiency vir...
Accumulating evidence suggests that HIV-infected individuals have an increased risk of cardiovascula...
Metabolic complications continue to play a major role in the management of HIV infection. Dyslipidem...
Metabolic complications continue to play a major role in the management of HIV infection. Dyslipidem...
The objective proposed by various health authorities for the year 2010 is to reduce CHD deaths to no...
The objective proposed by various health authorities for the year 2010 is to reduce CHD deaths to no...
AbstractMetabolic complications continue to play a major role in the management of HIV infection. Dy...
Dyslipidaemia is a common metabolic condition occurring in people with HIV (PWH), whether treated or...
Highly active antiretroviral therapy (HAART) reduces AIDS-related morbidity and mortality, however i...
The number of people that live with HIV continue to increase due to ample access to antiretroviral t...
Lipid abnormalities are prevalent among persons living with HIV infection and contribute to increasi...
Dyslipidemia is a change in serum lipids levels, which is associated with increased risk of cardiova...
AbstractMetabolic complications continue to play a major role in the management of HIV infection. Dy...
none6noThe introduction of potent combination antiretroviral therapy (cART) has had a remarkable imp...